The Global Injection Grade Dextrose Anhydrous Market was valued at USD 1.65 Billion in 2025 and is projected to reach USD 2.80 Billion by 2034, growing at a Compound Annual Growth Rate (CAGR) of 6.1% during the forecast period (2025–2034). This robust growth is driven by the rising global prevalence of chronic diseases requiring hospitalization, an increasing number of surgical procedures, and the critical role of dextrose in parenteral nutrition formulations for patients unable to consume food orally.

As the pharmaceutical industry demands higher standards of purity and safety for injectable drugs, the focus intensifies on the key manufacturers who produce this essential excipient. In this blog, we profile the Top 10 Companies in the Injection Grade Dextrose Anhydrous Industry—a combination of global ingredient specialists and regional powerhouses shaping the future of pharmaceutical manufacturing.

---

🔟 1. Roquette

Headquarters: Lestrem, France
Key Offering: Pharmaceutical Grade Dextrose Anhydrous

Roquette is a globally recognized leader in plant-based ingredients and a major supplier of high-purity pharmaceutical excipients. The company offers injection grade dextrose anhydrous that complies with stringent pharmacopeial standards like USP, EP, and JP. Its extensive product portfolio supports the formulation of intravenous solutions and parenteral nutrition products worldwide.

Quality & Innovation Initiatives:

• Investment in continuous process improvement for impurity control

• Global supply chain reliability for pharmaceutical customers

• Commitment to sustainable sourcing and manufacturing practices

Download FREE Sample Report: Injection Grade Dextrose Anhydrous Market – View in Detailed Research Report

---

9️⃣ 2. Cargill, Incorporated

Headquarters: Wayzata, Minnesota, USA
Key Offering: Dextrose Anhydrous, USP Grade

Cargill is a leading global provider of food, agriculture, and industrial products, including a range of pharmaceutical-grade carbohydrates. Its dextrose anhydrous is manufactured under strict quality controls to ensure it meets the requirements for injectable drug formulations, serving major pharmaceutical companies and contract manufacturers.

Quality & Innovation Initiatives:

• Vertically integrated supply chain from corn to finished product

• Focus on product consistency and batch-to-batch uniformity

---

8️⃣ 3. Tate & Lyle PLC

Headquarters: London, United Kingdom
Key Offering: Dextrose Anhydrous for Injectable Applications

Tate & Lyle is a prominent supplier of specialty food and pharmaceutical ingredients. The company provides high-purity dextrose anhydrous that is essential for IV fluids and other sterile preparations. Its global manufacturing footprint ensures a reliable supply for the healthcare sector.

Quality & Innovation Initiatives:

• R&D focused on enhancing purity profiles for critical applications

• Strategic partnerships with pharmaceutical innovators

---

7️⃣ 4. Grain Processing Corporation (GPC)

Headquarters: Muscatine, Iowa, USA
Key Offering: Pure-Dent® Dextrose (USP Grade)

As a subsidiary of Kent Corporation, GPC is a key North American manufacturer of corn-based ingredients. Its Pure-Dent® line includes dextrose anhydrous that meets USP specifications, making it suitable for demanding pharmaceutical applications where purity is non-negotiable.

Quality & Innovation Initiatives:

• Advanced purification technologies

• GMP compliant manufacturing facilities

---

6️⃣ 5. Agrana Group

Headquarters: Vienna, Austria
Key Offering: Pharmaceutical Dextrose Anhydrous

Agrana is a leading European producer of sugar, starch, and fruit preparations. The company’s ingredient division supplies pharmaceutical-grade dextrose anhydrous to the European market, adhering to the high standards of the European Pharmacopoeia.

Quality & Innovation Initiatives:

• Strong focus on regional supply chain resilience

• Commitment to meeting specific customer and regulatory requirements

Download FREE Sample Report: Injection Grade Dextrose Anhydrous Market – View in Detailed Research Report

---

5️⃣ 6. Gulshan Polyols Ltd.

Headquarters: New Delhi, India
Key Offering: Dextrose Anhydrous, IP/BP/USP Grades

Gulshan Polyols is a major Indian manufacturer of industrial and pharmaceutical-grade carbohydrates. The company produces dextrose anhydrous that conforms to various international pharmacopoeias, catering to both domestic pharmaceutical companies and export markets.

Quality & Innovation Initiatives:

• Expansion of manufacturing capacities to meet growing demand

• Cost-effective production for competitive pricing

---

4️⃣ 7. Sukhjit Starch & Chemicals Ltd.

Headquarters: Phagwara, Punjab, India
Key Offering: Pharma Grade Dextrose Anhydrous

Sukhjit Starch is a well-established player in the Indian starch and starch derivative market. The company supplies pharmaceutical-grade dextrose anhydrous to formulation manufacturers, leveraging its integrated operations from maize processing to refined products.

Quality & Innovation Initiatives:

• Focus on the growing domestic pharmaceutical sector

• Investment in quality assurance infrastructure

---

3️⃣ 8. SPI Pharma

Headquarters: Wilmington, Delaware, USA
Key Offering: High-Purity Dextrose Excipients

SPI Pharma, part of the Associated British Foods group, specializes in pharmaceutical excipients. The company offers highly refined dextrose anhydrous designed for use in parenteral formulations, emphasizing low endotoxin levels and superior solubility.

Quality & Innovation Initiatives:

• Expertise in excipient functionality and performance

• Technical support for formulation development

---

2️⃣ 9. Xiwang Sugar Holdings Company Ltd.

Headquarters: Binzhou, Shandong, China
Key Offering: Dextrose Anhydrous for Pharmaceutical Use

Xiwang Sugar is one of China’s leading producers of starch sweeteners. The company manufactures dextrose anhydrous that meets the requirements of the Chinese Pharmacopoeia and other international standards, serving a vast and growing pharmaceutical market in Asia.

Quality & Innovation Initiatives:

• Large-scale, integrated production capabilities

• Strategic positioning within the Asia-Pacific supply chain

---

1️⃣ 10. Tereos

Headquarters: Lille, France
Key Offering: Dextrose Anhydrous for Injectable Solutions

Tereos is a major international agro-industrial group with a significant presence in sugar and starch products. Its ingredient division supplies high-purity dextrose anhydrous to the pharmaceutical industry, ensuring compliance with rigorous quality standards for sterile applications.

Quality & Innovation Initiatives:

• Sustainable agricultural sourcing for raw materials

• Continuous investment in refining and purification technologies

Get Full Report Here: Injection Grade Dextrose Anhydrous Market – View in Detailed Research Report

---

💉 Outlook: The Future of Injection Grade Dextrose Anhydrous Is Precision and Purity

The injection grade dextrose anhydrous market is evolving to meet the pharmaceutical industry’s escalating demands for safety and efficacy. As regulatory scrutiny increases and drug formulations become more complex, manufacturers are investing in advanced purification technologies and robust quality systems.

📈 Key Trends Shaping the Market:

• Accelerated demand for parenteral nutrition driven by an aging global population and rising chronic diseases

• Stringent regulatory mandates for impurity profiling, including limits on endotoxins and pyrogens

• Growth of contract manufacturing for injectable drugs, creating a stable demand for high-quality excipients

• Expansion of pharmaceutical production capacity in Asia-Pacific, fostering regional supply chains

Get Full Report Here: Injection Grade Dextrose Anhydrous Market – View in Detailed Research Report

The companies listed above are not only supplying a critical pharmaceutical ingredient—they are enabling the development of life-saving therapies and ensuring the highest standards of patient safety worldwide.